Driving for Pole Position(ing) in Pharma

With the dynamic pace of change in pharma today, strong clinical data alone may no longer be enough to secure market leadership. Bringing clarity from complexity stakeholders process more information than ever means the window to inform understanding and drive choice is narrowing.

Positioning should help brands differentiate. In newer or evolving markets, it can help define how the category itself develops; shaping how stakeholders understand the unmet need, the treatment landscape, and the role a new therapy should play.

Yet many companies are still approach positioning too late, treating it as a downstream commercialization exercise rather than a strategic discipline that should shape development decisions from the beginning.